Last updated: August 3, 2026
Sponsor: Vanderbilt University Medical Center
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Progressive Supranuclear Palsy
Treatment
Art Thrapy
Clinical Study ID
NCT06588673
240791
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of progressive supranuclear palsy
Have the cognitive ability to provide informed consent
Exclusion
Exclusion Criteria:
Primary neurological diagnosis other than progressive supranuclear palsy
Cognition too impaired to provide informed consent
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Art Thrapy
Phase:
Study Start date:
January 14, 2025
Estimated Completion Date:
July 02, 2027